Publisher Summary This chapter focuses on the attempts to further characterize the
relationship of NPY to NE release under physiological and pathophysiological conditions …

Neuropeptide Y (NPY) is contained in and coreleased with norepinephrine (NE) from
sympathetic nerves innervating vascular and cardiac tissues. The effects of NPY infusion on …

Neuropeptide Y (NPY) is co-released with noradrenaline from sympathetic nerves, has a
strong vasoconstrictive action, and causes an attenuation of parasympathetic action in …

Neuropeptide Y (NPY) is thought to be co-released with catecholamines in response to
major cardiovascular stresses, but its relation to the release of catecholamines in response …

Neuropeptide Y (NPY) is coreleased with the classical transmitter noradrenaline in both the
peripheral and central nervous systems, and has been shown to potentiate the pressor …

The actions of neuropeptide Y (NPY) on the circulation is currently the subject of much
research that has been stimulated by findings of its co-storage and cooperation with …

The classical idea that cardiac performance is regulated by the two transmitter substances
noradrenaline and acetylcholine, derived from neurons of the sympathetic trunk and from the …

The cardiovascular system is richly innervated by sympathetic nerves containing
norepinephrine (NE) and neuropeptide Y (NPY). Although NE is considered a major …

Abstract purpose: Our objectives were to assess whether plasma neuropeptide Y (NPY)
levels are elevated in patients with congestive heart failure (CHF) and whether or not NPY …

Sympathetic nerve activity, including that in the kidney, is increased in heart failure with
increased plasma concentrations of norepinephrine and the vasoconstrictor cotransmitter …